Hallmark #6 of 12
The energy crisis that drives aging
Mitochondria are your cells' power plants. By age 70, OxPhos efficiency drops ~30%, NAD+ falls ~50%, and mitochondrial ROS leaks accelerate damage across every hallmark of aging. Fixing this is foundational.
Mitochondrial Dysfunction
Every high-energy organ — heart, brain, skeletal muscle — is acutely sensitive to mitochondrial output decline; VO2 max falls 7–10% per decade in sedentary adults and 3–4% in active ones, tracking almost perfectly with mitochondrial biogenesis capacity. Mitochondrial dysfunction is arguably the most systemically impactful hallmark because it simultaneously elevates ROS (feeding genomic instability and senescence), reduces SIRT3 antioxidant protection (worsening proteostasis), and impairs AMPK signaling (disabling autophagy). NAD+ (via NMN), CoQ10, and Zone 2 training collectively address Complex I efficiency, electron carrier supply, and biogenesis — three non-redundant mechanisms that compound when stacked.
7 compound interventions · 4 trackable biomarkers
Top interventions
- ANMN / NAD+ precursors
- ACa-AKG (TCA cycle)
- AZone 2 aerobic training
- BResveratrol (mitophagy)
- BR-Alpha Lipoic Acid
The Mechanism
The energy crisis — and why it cascades
Mitochondrial decline is driven by three converging failures. First, mtDNA mutation accumulation: mitochondrial DNA (37 genes) has no histone protection and minimal repair capacity. mtDNA mutation rate is 10–17× higher than nuclear DNA. By age 70, some cell types have mutation rates >20% in respiratory chain genes.
Second, NAD+ depletion: NAD+ is both the electron carrier feeding Complex I and the substrate for SIRT3 — the deacetylase that activates mitochondrial metabolic enzymes. As NAD+ drops, Complex I stalls, the ETC backs up, and electrons leak to oxygen, forming superoxide instead of being efficiently coupled to ATP synthesis.
Third, impaired mitophagy: damaged mitochondria are normally cleared by the PINK1/Parkin pathway — a quality control system that tags depolarized mitochondria for autophagy. With age, PINK1 expression declines and Parkin activity decreases, allowing damaged mitochondria to accumulate and continue secreting ROS and pro-apoptotic factors.
The consequence is mitohormesis disruption: mild mitochondrial stress is normally beneficial (hormesis), triggering adaptive responses via PGC-1α, AMPK, and NRF2. Severe, chronic mitochondrial stress overwhelms these pathways and drives the inflammatory phenotype, mtDNA release into cytoplasm (activating cGAS-STING), and systemic age acceleration.
Key Molecular Axes
NAD+ → SIRT3
Activates OxPhos enzymes, IDH2, SOD2; declined by ~50% by age 60
AMPK → PGC-1α
Drives mitochondrial biogenesis; suppressed by mTORC1 hyperactivation in aging
PINK1 / Parkin
Mitophagy quality control; removes depolarized mitochondria; declines with age
Monitoring
Biomarkers that track mitochondrial health
Evidence-Graded Interventions
Mitochondrial interventions with human evidence
Listed in order of evidence strength.
NMN / NAD+ precursors
Tier ARestores NAD+ declined ~50% by age 60. Human trials show improved muscle insulin sensitivity and aerobic capacity.
Ca-AKG (TCA cycle)
Tier AFuels mitochondrial respiration and collagen synthesis. 12–14% median lifespan extension in mice.
Zone 2 aerobic training
Tier AThe single strongest lifestyle intervention for mitochondrial biogenesis via PGC-1α.
Resveratrol (mitophagy)
Tier BPromotes clearance of damaged mitochondria via SIRT1/PINK1 pathway.
R-Alpha Lipoic Acid
Tier BCofactor for pyruvate dehydrogenase and complex enzymes; recycles antioxidants in the mitochondrial matrix.
Taurine
Tier BAge-depleted osmolyte; Singh 2023 Science links deficiency to hallmarks and extends lifespan in animal models.
CoQ10 (Ubiquinol)
Tier BEssential electron carrier in Complex I–III of the electron transport chain. Declines ~50% by age 60; ubiquinol form achieves 3× higher plasma levels. Meta-analysis of 17 RCTs confirms reduced hs-CRP and IL-6 (PMID 26267690).
Urolithin A (mitophagy)
Tier APhase 2 RCT confirmed urolithin A activates mitophagy and improves aerobic capacity and muscle strength in adults ≥65 vs placebo (PMID 35391504).
Build a mitochondrial protocol.
The Stack Architect maps your energy and mitochondrial goals to evidence-graded compounds and shows which hallmarks each compound targets.